| Model Number |
VICM5 13.7 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Blurred Vision (2137)
|
| Date of Event |
03/19/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6-investigation type 4110: lens work order search- no similar complaint event(s) within associated lots were found.Claim# (b)(4).
|
| |
|
Event or Problem Description
|
|
The reporter indicated that a 13.7mm vicm5 13.7 implantable collamer lens of -9.50 diopter was implanted into the patients right eye (od) on (b)(6) 2024.Excessive vault and pain with headaches have been reported.The lens remains implanted.If additional information is received a supplemental medwatch report will be submitted.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the reporter indicated that a 13.7mm vicm5 13.7 implantable collamer lens of -9.50 diopter was implanted into the patients right eye (od) on (b)(6) 2024.Excessive vault and pain with headaches have been reported.On (b)(6) 2024 the lens was explanted and on the same day a replacement lens of a shorter length was implanted.No update on the patients post op condition.If additional information is received a supplemental medwatch report will be submitted.Explant date: (b)(6) 2024.Claim# (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information" b5- update given for patient 3 month post op exams as follows: on (b)(6) 2024: patient is ok / vault ok 580 / iop 21 - under treatment (diamox = acétazolamide).On (b)(6) 2024: peri orbital pain / vault ok / iop 32 - under treatment (diamox).On (b)(6) 2024: vault ok / iop 22 - under treatment (diamox).On (b)(6) 2024: vault ok / iop 25 - no treatment (no diamox).On (b)(6) 2024: peri orbital pain and nausea / vault ok / iop 34 - restart of treatment (diamox).On (b)(6) 2024: vault ok / iop 30 - under treatment (diamox).On (b)(6) 2024: slt / iop 22 - under treatment (diamox).On (b)(6) 2024: slt / iop 12 - under treatment (diamox).On (b)(6) 2024: iop 12.5 - no treatment (no diamox).On (b)(6) 2024: iop 13 - no treatment (no diamox).On (b)(6) 2024: no pain / iop 14 - no treatment (no diamox).Claim # (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional data: h3 - device evaluation: the lens was returned dry in a microcentrifuge vial with residue/debris on the product.Visual inspection found the haptic deformed and stretched out.Dimensional inspection found the lens to be within specifications.Claim# (b)(4).
|
| |
|
Search Alerts/Recalls
|